Silverarc Capital Management’s Sanofi SNY Stock Holding History

Silverarc Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-220,000	Closed	-$10.9M	–	95
2023 Q4	$10.9M	Buy	+220,000	New	+$10.8M	3.26%	9

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Silverarc Capital Management's SNY Position: Q1 2024 in Review

Silverarc Capital Management sold out of Sanofi (SNY) in Q1 2024, closing a stake of 220,000 shares — an estimated $10.9M sold.

Silverarc Capital Management first reported a position in SNY in Q4 2023 and held it in 1 quarter. The position peaked at $10.9M in Q4 2023. 713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

Silverarc Capital Management reported no remaining Sanofi position as of Q1 2024 after selling out during the quarter.
Silverarc Capital Management sold 220,000 Sanofi shares in Q1 2024, an estimated $10.9M.
Silverarc Capital Management first reported a position in Sanofi in Q4 2023 and held it in 1 quarter.
Silverarc Capital Management's Sanofi position peaked at $10.9M in Q4 2023.
713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Silverarc Capital Management's 13F filing for Q1 2024, filed 15 May 2024.